Furthermore, overexpression of C/EBPβ repressed the mRNA expression levels of B-Cell CLL/Lymphoma 2 (Bcl2) and a cellular oncogene (c-Myc) compared to controls (Fig. 5C). The gene discussed is CEBPB; the disease is B-cell chronic lymphocytic leukemia.